Literature DB >> 22430249

IL-27 induction of IL-21 from human CD8+ T cells induces granzyme B in an autocrine manner.

Akanksha Mittal1, Gopal Murugaiyan, Vanessa Beynon, Dan Hu, Howard L Weiner.   

Abstract

Interleukin (IL)-27 exerts an anti-inflammatory effect on human and mice CD4(+) T cells by inducing IL-10-producing T regulatory 1 cells through induction of IL-21. However, the role of IL-27 and how it regulates IL-21 from human CD8(+) T cells is unclear. Here, we show that the IL-27 receptor is expressed on human CD8(+) T cells and stimulation of human naïve CD8(+) T cells in the presence of IL-27 leads to an increase in IL-21 and interferon (IFN)-γ production. IL-21 induction in IL-27-stimulated human CD8(+) T cells correlates specifically with expression of the transcription factor T-bet. IL-27 stimulation of naïve CD8(+) T cells induces a double-positive T-bet(+) IL-21(+) expressing CD8(+) T-cell population. Furthermore, IL-27 stimulation of human naïve CD8(+) T cells greatly increases expression of granzyme B. Antibody-mediated neutralization of IL-21 abrogates IL-27-induced granzyme B expression. Moreover, direct addition of IL-21 greatly amplifies granzyme B expression in human naïve CD8(+) T cells. Our findings identify IL-27-induced IL-21 as a key autocrine regulator of granzyme B expression in human CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430249      PMCID: PMC7293547          DOI: 10.1038/icb.2012.14

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  41 in total

1.  IL-27 increases the proliferation and effector functions of human naïve CD8+ T lymphocytes and promotes their development into Tc1 cells.

Authors:  Raphael Schneider; Teodora Yaneva; Diane Beauseigle; Lama El-Khoury; Nathalie Arbour
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

2.  Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.

Authors:  Noriko Morishima; Toshiyuki Owaki; Masayuki Asakawa; Sadahiro Kamiya; Junichiro Mizuguchi; Takayuki Yoshimoto
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

3.  IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Rocio Lopez-Diego; Lisa M Maier; David E Anderson; Howard L Weiner
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

4.  Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial.

Authors:  Ian D Davis; Ben Brady; Richard F Kefford; Michael Millward; Jonathan Cebon; Birte K Skrumsager; Ulrik Mouritzen; Lasse Tengbjerg Hansen; Kresten Skak; Dorthe Lundsgaard; Klaus Stensgaard Frederiksen; Paul E G Kristjansen; Grant McArthur
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

5.  In vivo antitumor efficacy of interleukin-21 in combination with chemotherapeutics.

Authors:  Kresten Skak; Henrik Søndergaard; Klaus Stensgaard Frederiksen; Eva Ehrnrooth
Journal:  Cytokine       Date:  2009-08-25       Impact factor: 3.861

6.  Potent antitumor activity of interleukin-27.

Authors:  Masayuki Hisada; Sadahiro Kamiya; Koji Fujita; Maria Laura Belladonna; Tatuya Aoki; Yasuhisa Koyanagi; Junichiro Mizuguchi; Takayuki Yoshimoto
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

7.  Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.

Authors:  Denise C Fitzgerald; Bogoljub Ciric; Tarik Touil; Heather Harle; Julia Grammatikopolou; Jayasri Das Sarma; Bruno Gran; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

8.  Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.

Authors:  Gopal Murugaiyan; Akanksha Mittal; Howard L Weiner
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

9.  Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

Authors:  Rong Zeng; Rosanne Spolski; Steven E Finkelstein; SangKon Oh; Panu E Kovanen; Christian S Hinrichs; Cynthia A Pise-Masison; Michael F Radonovich; John N Brady; Nicholas P Restifo; Jay A Berzofsky; Warren J Leonard
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

10.  Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells.

Authors:  Andrea L Wurster; Vikki L Rodgers; Abhay R Satoskar; Matthew J Whitters; Deborah A Young; Mary Collins; Michael J Grusby
Journal:  J Exp Med       Date:  2002-10-07       Impact factor: 14.307

View more
  14 in total

Review 1.  Interleukin-21: a double-edged sword with therapeutic potential.

Authors:  Rosanne Spolski; Warren J Leonard
Journal:  Nat Rev Drug Discov       Date:  2014-04-22       Impact factor: 84.694

Review 2.  The Yin and Yang aspects of IL-27 in induction of cancer-specific T-cell responses and immunotherapy.

Authors:  Ming-Song Li; Zhenzhen Liu; Jin-Qing Liu; Xiaotong Zhu; Zhihao Liu; Xue-Feng Bai
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

3.  Skin Injury Activates a Rapid TRPV1-Dependent Antiviral Protein Response.

Authors:  Vivian Lei; Chelsea Handfield; Jeffery T Kwock; Stephen J Kirchner; Min Jin Lee; Margaret Coates; Kaiyuan Wang; Qingjian Han; Zilong Wang; Jennifer G Powers; Sarah Wolfe; David L Corcoran; Brian Fanelli; Manoj Dadlani; Ru-Rong Ji; Jennifer Y Zhang; Amanda S MacLeod
Journal:  J Invest Dermatol       Date:  2022-01-07       Impact factor: 7.590

4.  Immune activation is associated with CD8 T cell interleukin-21 production in HIV-1-infected individuals.

Authors:  LaTonya D Williams; Nilesh Amatya; Anju Bansal; Steffanie Sabbaj; Sonya L Heath; Irini Sereti; Paul A Goepfert
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

Review 5.  Interleukin-21 and T follicular helper cells in HIV infection: research focus and future perspectives.

Authors:  Suresh Pallikkuth; Savita Pahwa
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

6.  The role of IL-27 in the induction of anti-tumor cytotoxic T lymphocyte response.

Authors:  Zhenzhen Liu; Jianhua Yu; William E Carson; Xue-Feng Bai
Journal:  Am J Transl Res       Date:  2013-08-15       Impact factor: 4.060

Review 7.  Biology of IL-27 and its role in the host immunity against Mycobacterium tuberculosis.

Authors:  Abualgasim Elgaili Abdalla; Qiming Li; Longxiang Xie; Jianping Xie
Journal:  Int J Biol Sci       Date:  2015-01-05       Impact factor: 6.580

8.  Committed Tc17 cells are phenotypically and functionally resistant to the effects of IL-27.

Authors:  Mohamed El-Behi; Hong Dai; Joao G Magalhaes; Daniel Hwang; Guang-Xian Zhang; Abdolmohamad Rostami; Bogoljub Ciric
Journal:  Eur J Immunol       Date:  2014-10       Impact factor: 5.532

9.  Tristetraprolin inhibits macrophage IL-27-induced activation of antitumour cytotoxic T cell responses.

Authors:  Qinghong Wang; Huan Ning; Hui Peng; Lin Wei; Rong Hou; Daniel F Hoft; Jianguo Liu
Journal:  Nat Commun       Date:  2017-10-11       Impact factor: 14.919

Review 10.  Interleukin-27 Functional Duality Balances Leishmania Infectivity and Pathogenesis.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Prashant Chauhan; Ashok Patidar; Arup Sarkar; Iraj Sharifi; Bhaskar Saha
Journal:  Front Immunol       Date:  2020-08-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.